Recent Updates
Recently added Catalysts
ENOV Positive Sentiment Score: 70/100

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Key Takeaway: Enovis Corporation announced it will host a conference call on November 6th, 2024, to discuss its third quarter financial results. The call is set for 8:30 a.m. Eastern Time, and attendees can participate via a webcast or by dialing in. Enovis emphasizes its dedication to innovation within medical technology, focusing on solutions that improve patient outcomes. The company encourages investors to stay updated through their dedicated Investor Relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is hosting a conference call to discuss financial results, indicating transparency.
  • The company is committed to innovation and improvement in medical technology.
  • The call provides an opportunity for investors to engage directly with the company's leadership.

Full Press Release Details

Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results on Wednesday, November 6th, 2024 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on ir.enovis.com.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Vice President, Investor Relations

Frequently Asked Questions

When is Enovis’ Q3 2024 financial results call?

The call will be on November 6, 2024, at 8:30 a.m. Eastern Time.

How can I access the Enovis conference call webcast?

Investors can access the live webcast via a link on the Enovis website.

What is Enovis Corporation known for?

Enovis is a medical technology growth company focused on innovative solutions.

How can I reach Enovis Investor Relations?

You can contact Enovis Investor Relations at investorrelations@enovis.com.

Where can I find Enovis’ press releases?

Press releases are available on the Enovis Investor Relations website.

Last updated: Oct 10, 2024